Bayer’s pharma unit is seeking new sources of growth to counteract falling revenue anticipated in coming years from ...

Bayer cut its full-year earnings target after a tough agricultural market hit its crop-science division, and said it heads ...

Bayer now says it expects to make €3 billion ... results of the phase 3 ARASENS trial in the New England Journal of Medicine. The study showed that adding Nubeqa to standard therapy with anti ...

According to The Wall Street Journal, Bayer started putting in the cotton ... We've all been there: reaching for the medicine cabinet with a splitting headache, opening the new pill bottle ...

Leadership Strategist Dan Pontefract covers leadership and culture. Heike Prinz of Bayer's Board of Management recently articulated the company's predicament, stating, "Bayer is currently in a ...

AI in medicine, new genomic techniques (NGTs) in agriculture, and cultivated meat Berlin, Germany, January 20, 2025 – As ...

Bayer’s Parkinson’s disease cell therapy ... circuit therapeutics and associate professor at the Icahn School of Medicine at Mount Sinai, said in the release. “New therapies with potential ...

Johnson & Johnson (JNJ) traded flat after exceeding Street forecasts with its Q4 2024 results thanks mainly to its Innovative ...

As we usher in 2025, it’s the perfect time to prioritize health and wellness. Recently, Registered Dietitian & Nutritionist Kelly Bristow from ...